Skip to main content
GENESIS IBRC INDIA LIMITED logo

GENESIS IBRC INDIA LIMITED — Investor Relations & Filings

Ticker · 514336 ISIN · INE194N01016 BSE.NS Manufacturing
Filings indexed 311 across all filing types
Latest filing 2025-09-30 AGM Information
Country IN India
Listing BSE.NS 514336

About GENESIS IBRC INDIA LIMITED

https://genesisiil.com/

Genesis IBRC India Limited is a biotechnology-driven enterprise focused on the research, development, and commercialization of advanced biological solutions. The company specializes in the production of high-quality probiotics and industrial enzymes tailored for diverse applications. Its product portfolio serves critical sectors including aquaculture, poultry, animal husbandry, and human nutrition, providing microbial formulations designed to enhance growth, immunity, and overall health. In the industrial segment, the company develops enzymatic solutions for the textile, leather, and paper processing sectors to improve efficiency and environmental sustainability. Genesis IBRC emphasizes innovation through its dedicated research facilities, focusing on strain selection and fermentation technology to deliver standardized and effective biochemical products. The company aims to provide science-based alternatives to traditional chemical processes across global markets.

Recent filings

Filing Released Lang Actions
Proceedings of AGM
AGM Information Classification · 95% confidence The document is a detailed communication about the outcome and proceedings of the 33rd Annual General Meeting (AGM) of Genesis IBRC India Limited held on 30th September 2025. It includes information about the meeting's conduct, voting procedures, resolutions passed, director appointments, auditor appointments, and other AGM-related formalities. The document does not contain financial statements or detailed financial analysis but focuses on the AGM event itself and its results. Therefore, it fits the category of AGM Information (AGM-R) rather than an Annual Report or Voting Results announcement, as it provides the meeting proceedings and outcome details rather than just voting results or a report publication notice.
2025-09-30 English
Closure of trading window
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to the BSE Limited Corporate Relations Department, notifying the closure of the trading window for insiders in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. It specifies the period of closure related to the upcoming unaudited financial results for the second quarter and half year ended 30th September 2025. The document does not contain any financial data or results itself, nor does it announce or attach any report. It is an announcement related to insider trading compliance and trading restrictions, not a financial report or earnings release. Given the nature and content, this fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2025-09-26 English
33rd annual report
Annual Report Classification · 100% confidence The document is titled as the '33rd Annual Report 2025' for Genesis IBRC India Limited and includes detailed contents such as Company Information, Notice of AGM, Directors Report, Secretarial Audit Report, Corporate Governance Report, Audit Report, Financials, and Notes to Accounts. It also contains the Notice of the 33rd Annual General Meeting scheduled for 30th September 2025, with agenda items including adoption of audited financial statements for FY 2024-25 and appointment of auditors. The document is comprehensive, over 15,000 characters, and contains substantive financial data and governance information typical of an Annual Report. It is not merely an announcement or a proxy statement but the full annual report itself. Therefore, the correct classification is Annual Report (10-K). FY 2025
2025-09-03 English
Notice of 33rd Annual General Meeting
Annual Report Classification · 100% confidence The document is a detailed notice and accompanying materials for the 33rd Annual General Meeting (AGM) of Genesis IBRC India Limited for the financial year 2024-25. It includes the Notice of AGM, Directors Report, Secretarial Audit Report, Corporate Governance Report, Audit Report, Financials, and other related documents typically found in an Annual Report. The document explicitly states it is the 'Annual Report 2024-25' and includes comprehensive company information, financial statements, and governance details. The length of the document (15,000 characters) and the inclusion of substantive financial data and reports confirm it is the full Annual Report, not just an announcement or notice. Therefore, the correct classification is Annual Report (10-K). FY 2025
2025-09-03 English
As per the attached outcome
Board/Management Information Classification · 95% confidence The document is a formal communication from Genesis IBRC India Limited to the BSE Limited Corporate Relations Department. It announces the outcome of a Board Meeting held on 29.08.2025. The key points include scheduling the 33rd Annual General Meeting, approval of the Notice of AGM and Director's report, and appointments of a Secretarial Auditor and Statutory Auditors for a term of 5 years. The document references SEBI regulations and provides detailed disclosures about the appointments. There are no financial statements or detailed financial data presented, nor is this a transcript or presentation. The document is an official announcement of board decisions, specifically about auditor appointments and AGM scheduling, which fits the category of Board/Management Information (MANG). It is not an Annual Report, Audit Report, or any other report type, but a regulatory announcement about management decisions and appointments.
2025-08-29 English
Submission of results for the quarter ended 30.06.2025
Regulatory Filings
2025-08-14 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.